Cerca un progetto di ricerca

Cerca un progetto di ricerca

Altra/e opzione/i di ricerca

155 Risultato/i

Progetti di ricerca

Li-Fraumeni syndrome-cancer predisposition syndrome registry Deutsches Krebsforschungszentrum KITZ - Hopp-Kindertumorzentrum Heidelberg

Li-Fraumeni syndrome-cancer predisposition syndrome registry Medizinische Hochschule Hannover Klinik für Pädiatrische Hämatologie und Onkologie

Structure of the Neurofibromatosis Type 1 Protein Medizinische Universität Innsbruck Sektion für Biologische Chemie

i-PAD: Integrative Multi-Omics Analysis of Primary Antibody Deficiency (PAD) Patients for Stratification - AT AKH BT 25.3 Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases

Molecular and functional pathogenesis in NF1 and related diseases UZ Leuven - Campus Gasthuisberg Centrum Menselijke Erfelijkheid - UZ Leuven

Indentification and characterization of Merlin interacting proteins University of Alberta Department of Medical Genetics

Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers Hospital for Sick Children, Research Institute

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer Hospital for Sick Children, Research Institute

Clinical research study on neurofibromatosis type 1 in Finland University of Turku Institute of Biomedicine

NIRBTEST: New strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles - FR Institution: Information not provided - FR

Neurofibromatosis type 1 Disease Model Faculty of Medicine and University Hospital Motol Department of Pediatrics

First preclinical validation of LOOK / ROCK inhibitors for the treatment of neurofibromatosis type 1 UPR4301 Centre de biophysique moléculaire (CBM) Equipe signalisation cellulaire et neurofibromatose

Implementation of non-invasive prenatal diagnosis of rare and severe monogenic diseases CHU Paris Centre - Hôpital Cochin, Site Cochin Service de génétique et biologie moléculaires

Constitutive hematologic diseases: clinical and therapeutic research, molecular biology CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis Service d'hématologie pédiatrique

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR Muséum National d'Histoire Naturelle Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FROGH : FRench Regional Origins in Genetics for Health - FR Institut de Recherche en Santé - Université de Nantes L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

A prospective, international, multicentre cohort study (observational study) study on patients with profound combined immunodeficiency (P-CID) CCI am Universitätsklinikum Freiburg Centrum für Chronische Immundefizienz

LRBA deficiency: clinical phenotype, biological pathomechanisms and murine model CCI am Universitätsklinikum Freiburg Centrum für Chronische Immundefizienz

Epigenetic analysis in patients with Primary Antibody Deficiencies CCI am Universitätsklinikum Freiburg Centrum für Chronische Immundefizienz

GAIN: German network for research and therapy optimization of patients with multi-organ autoimmune diseases CCI am Universitätsklinikum Freiburg Centrum für Chronische Immundefizienz

ADDRess: Translational research for patients with abnormal DNA Damage Response Deutsches Krebsforschungszentrum KITZ - Hopp-Kindertumorzentrum Heidelberg

ADDRess: Translational research for patients with abnormal DNA Damage Response Universitäts-Frauenklinik Heidelberg Frauenheilkunde und Geburtshilfe

GeNeRARe: German Network for RASopathies Institute of Comparative Molecular Endocrinology der Universität Ulm Cirstea Lab

ADDRess: Translational research for patients with abnormal DNA Damage Response Universität Würzburg - Biozentrum Institut für Humangenetik

GeNeRARe: German Network for RASopathies UKE - Universitätsklinikum Hamburg-Eppendorf Institut für Humangenetik

GeNeRARe: German Network for RASopathies Universitätsmedizin Göttingen Klinik für Thorax-, Herz- und Gefäßchirurgie

GAIN: German network for research and therapy optimization of patients with multi-organ autoimmune diseases Medizinische Hochschule Hannover Klinik für Rheumatologie und Immunologie

GeNeRARe: German Network for RASopathies Heinrich-Heine-Universität Düsseldorf Institut für Biochemie und Molekularbiologie II

ADDRess: Translational research for patients with abnormal DNA Damage Response Universitätsklinikum Düsseldorf Institut für Pathologie

GeNeRARe: German Network for RASopathies Otto-von-Guericke-Universität Magdeburg Abteilung Genetik & Molekulare Neurobiologie

GAIN: German network for research and therapy optimization of patients with multi-organ autoimmune diseases Universitätsklinikum Schleswig-Holstein - Campus Kiel Klinik für Innere Medizin I

Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine Research Institute of Environmental Medicine, Nagoya University

Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability Research Institute of Environmental Medicine, Nagoya University

Formation of integrated omics analysis base of refractory diseases in children and perinatal period National Center for Child Health and Development Research Institute

Il macchinario di trasporto implicato nelle ciliopatie: un nuovo protagonista nell'assemblaggio della sinapsi immunologica nei linfociti t e un bersaglio di malattia nell'immunodeficienza comune variabile Università degli Studi di Siena Dipartimento di Biologia Evolutiva

The genetic basis and pathophysiology of dyskeratosis congenita, aplastic anaemia, myelodysplasia and related disorders. Study of the genes DKC1, TERC, TERT, TIN2, NOP10, NHP2, C16orf57 and TCAB1 and new gene discovery Barts and The London School of Medicine and Dentistry Centre for Paediatrics

Integrative multi-omics analysis of primary antibody deficiency (PAD) patients for stratification according to cellular pathways IJC - Instituto de Investigación contra la Leucemia Josep Carreras, Campus HGTiP Grupo de Epigenética y enfermedades inmunitarias

Bioinformatics developments based on network and systems biology to identify new candidate genes for rare genetic diseases Fundación Jiménez Díaz Área de Genética y Genómica

Targeting tumors with nf1 loss Institution: Information not provided - US

A powerful web-based discovery platform for rare disease genetics Institution: Information not provided - US

Functional and translational studies of runx1 and cbfb in hematopoiesis Institution: Information not provided - US

Neuro-ophthalmic mechanisms of disease Institution: Information not provided - US

Tnf-receptors and programmed cell death in regulation of autoimmunity Institution: Information not provided - US

Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis Institution: Information not provided - US

Mechanisms of nf1 pathophysiology underlying hyperactivity Institution: Information not provided - US

Social competence in youth with neurofibromatosis type 1 Institution: Information not provided - US

Genetic basis of immunodeficiency diseases Karolinska Institutet - Huddinge Department of laboratory medicine

Novel immunodeficiency unravels immune homeostasis mechanism AKH BT 25.3 Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases

Empowering Families through Technology: a mobile-health project to reduce the TAND identification and treatment gap (TANDem) Universitair Ziekenhuis Brussel Pediatric neurology / Neurologie Kinderen

Pathobiology and robosomal insufficiency in Shwachman-Diamond syndrome Hospital for Sick Children, Research Institute

Development of cell and gene therapy for blood disorders, in particularly Gaucher and Blackfan-Diamond diseases Seoul National University Hospital Molecular Diagnostics Laboratory

Pig models for Ataxia telangiectasia and Batten disease Faculty of Medicine and University Hospital Motol Department of Pediatrics

Modeling Rubinstein Taybi Syndrome Functionalization of a Rare Monogenic Disease and Therapeutic Potential of Stress Response Pathways in Neuropathies. Université Paris Diderot Unité Epigénétique et Destin Cellulaire CNRS UMR7216

RIBODBA: Blackfan-Diamond anemia: molecular mechanisms of a ribosomal disease Université Paul Sabatier Laboratoire de Biologie Moléculaire Eucaryote - UMR 5099

Phase IV Study: Status of the growth hormone/ insulin-like growth factor-1 axis in relation to growth failure, body weight and neuroprotection in children with Ataxia Telangiectasia Klinikum der Johann Wolfgang Goethe-Universität Frankfurt Schwerpunkt Allergologie, Pneumologie und Mukoviszidose

Preclinical Gene Therapy of Fanconi Anemia with Transposon-Based Approaches Paul-Ehrlich-Institut Abteilung Medizinische Biotechnologie

BioTyrosin - Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1: An international, multicenter, epidemiological protocol Centogene AG

Identification of molecular causes of human growth retardation in patients with features of Silver-Russell syndrome Universitätsklinikum Aachen Institut für Humangenetik

German Renal Cell Tumor Network: Molecular and clinical characterization of papillary renal cell carcinoma type II Universitätsklinikum des Saarlandes Klinik für Urologie und Kinderurologie

Evidence creation through nationwide surveillance of the progeria syndrome Werner syndrome and establishment ofa case registration system Graduate School of Medicine, Chiba University

Pathogenesis and novel therapeutic approarches in RASoapthies Tohoku University School of Medicine Department of Medical Genetics

Drug Screening and development of rapid diagnostic technique for the DNA methylation abnormality due to the mutation in histone modification enzymes Atomic Bomb Disease Institute, Nagasaki University Department of Human Genetics

Study of clinical features and treatment of imprinting disorders and related disorders National Center for Child Health and Development Department of Molecular Endocrinology

Development of RAS-related ALPS-like disease (RALD) therapy Tokyo Medical and Dental University Pediatrics and Developmental Biology

Screening of novel therapeutics for intellectual disability and autism in tuberous sclerosis complex Tokyo Metropolitan Institute of Medical Science Department of Brain Development and Neural Regeneration

Effetto del fondatore nelle muatazioni del gene ATM in famiglie italiane affette da Atassia Teleangiectasia A.O. S. Andrea Servizio di Genetica Medica

Studio della patogenesi dei fenomeni autoimmune nelle immunodeficienze primitive IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO U.O. di Immunoinfettivologia Pediatrica

Caratterizzazione clinica e molecolare di sindromi genetiche con cardiopatie congenite IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO U.O.C. Laboratorio di Genetica Medica

La Drosophila come organismo modello per lo studio della Nijmegen Breakage Syndrome e delle malattie ad essa correlate Sapienza Università di Roma Dipartimento di Genetica e Biologia Molecolare

Trasferimento delle nuove tecnologie nella diagnosi corrente di malattie genetiche rare a meccanismi eziopatogenetici multipli Istituto Auxologico Italiano Laboratorio di Biologia Molecolare

Production of vectors for gene therapy (Wiskott-Aldrich Syndrome and Metachromatic Leukodystrophy) Istituto San Raffaele Telethon per la Terapia Genica - TIGET Istituto San Raffaele Telethon per la Terapia Genica

Sindrome di Wiskott-Aldrich: caratterizzazione dei difetti immunologici e studi preclinici di terapia genica Istituto San Raffaele Telethon per la Terapia Genica - TIGET Unità di Ricerca Clinica

L'inibizione di DGK-alfa accende un nuovo interruttore che determina il destino cellulare dei linfociti T attivati: implicazioni per la terapia di XLP1 Università degli Studi del Piemonte Orientale Centro Interdisciplinare di Ricerca sulle Malattie Autoimmuni

L'inibizione di DGK-alfa accende un nuovo interruttore che determina il destino cellulare dei linfociti T attivati: implicazioni per la terapia di XLP1 Università degli Studi del Piemonte Orientale Dipartimento di Scienze Mediche

Screening per carcinoma midollare della tiroide e studio del genotipo nelle forme familiari Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza U.O.S. di Endocrinologia

Effectiveness and safety of mTOR-inhibitor in patients with tuberous sclerosis complex Oslo University Hospital, Ullevaal NevSom - Nasjonalt kompetansesenter for nevroutviklingsforstyrrelser og hypersomier

Li-Fraumeni syndrome-cancer predisposition syndrome registry
Deutsches Krebsforschungszentrum

KITZ - Hopp-Kindertumorzentrum Heidelberg

Li-Fraumeni syndrome-cancer predisposition syndrome registry
Medizinische Hochschule Hannover

Klinik für Pädiatrische Hämatologie und Onkologie

Structure of the Neurofibromatosis Type 1 Protein
Medizinische Universität Innsbruck

Sektion für Biologische Chemie

i-PAD: Integrative Multi-Omics Analysis of Primary Antibody Deficiency (PAD) Patients for Stratification - AT
AKH BT 25.3

Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases

Molecular and functional pathogenesis in NF1 and related diseases
UZ Leuven - Campus Gasthuisberg

Centrum Menselijke Erfelijkheid - UZ Leuven

Indentification and characterization of Merlin interacting proteins
University of Alberta

Department of Medical Genetics

Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Hospital for Sick Children, Research Institute

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Clinical research study on neurofibromatosis type 1 in Finland
University of Turku

Institute of Biomedicine

NIRBTEST: New strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles - FR
Institution: Information not provided - FR

Neurofibromatosis type 1 Disease Model
Faculty of Medicine and University Hospital Motol

Department of Pediatrics

First preclinical validation of LOOK / ROCK inhibitors for the treatment of neurofibromatosis type 1
UPR4301 Centre de biophysique moléculaire (CBM)

Equipe signalisation cellulaire et neurofibromatose

Implementation of non-invasive prenatal diagnosis of rare and severe monogenic diseases
CHU Paris Centre - Hôpital Cochin, Site Cochin

Service de génétique et biologie moléculaires

Constitutive hematologic diseases: clinical and therapeutic research, molecular biology
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis

Service d'hématologie pédiatrique

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle

Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes

L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

A prospective, international, multicentre cohort study (observational study) study on patients with profound combined immunodeficiency (P-CID)
CCI am Universitätsklinikum Freiburg

Centrum für Chronische Immundefizienz

LRBA deficiency: clinical phenotype, biological pathomechanisms and murine model
CCI am Universitätsklinikum Freiburg

Centrum für Chronische Immundefizienz

Epigenetic analysis in patients with Primary Antibody Deficiencies
CCI am Universitätsklinikum Freiburg

Centrum für Chronische Immundefizienz

GAIN: German network for research and therapy optimization of patients with multi-organ autoimmune diseases
CCI am Universitätsklinikum Freiburg

Centrum für Chronische Immundefizienz

ADDRess: Translational research for patients with abnormal DNA Damage Response
Deutsches Krebsforschungszentrum

KITZ - Hopp-Kindertumorzentrum Heidelberg

ADDRess: Translational research for patients with abnormal DNA Damage Response
Universitäts-Frauenklinik Heidelberg

Frauenheilkunde und Geburtshilfe

GeNeRARe: German Network for RASopathies
Institute of Comparative Molecular Endocrinology der Universität Ulm

Cirstea Lab

ADDRess: Translational research for patients with abnormal DNA Damage Response
Universität Würzburg - Biozentrum

Institut für Humangenetik

GeNeRARe: German Network for RASopathies
UKE - Universitätsklinikum Hamburg-Eppendorf

Institut für Humangenetik

GeNeRARe: German Network for RASopathies
Universitätsmedizin Göttingen

Klinik für Thorax-, Herz- und Gefäßchirurgie

GAIN: German network for research and therapy optimization of patients with multi-organ autoimmune diseases
Medizinische Hochschule Hannover

Klinik für Rheumatologie und Immunologie

GeNeRARe: German Network for RASopathies
Heinrich-Heine-Universität Düsseldorf

Institut für Biochemie und Molekularbiologie II

ADDRess: Translational research for patients with abnormal DNA Damage Response
Universitätsklinikum Düsseldorf

Institut für Pathologie

GeNeRARe: German Network for RASopathies
Otto-von-Guericke-Universität Magdeburg

Abteilung Genetik & Molekulare Neurobiologie

GAIN: German network for research and therapy optimization of patients with multi-organ autoimmune diseases
Universitätsklinikum Schleswig-Holstein - Campus Kiel

Klinik für Innere Medizin I

Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University

Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University

Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development

Research Institute

Il macchinario di trasporto implicato nelle ciliopatie: un nuovo protagonista nell'assemblaggio della sinapsi immunologica nei linfociti t e un bersaglio di malattia nell'immunodeficienza comune variabile
Università degli Studi di Siena

Dipartimento di Biologia Evolutiva

The genetic basis and pathophysiology of dyskeratosis congenita, aplastic anaemia, myelodysplasia and related disorders. Study of the genes DKC1, TERC, TERT, TIN2, NOP10, NHP2, C16orf57 and TCAB1 and new gene discovery
Barts and The London School of Medicine and Dentistry

Centre for Paediatrics

Integrative multi-omics analysis of primary antibody deficiency (PAD) patients for stratification according to cellular pathways
IJC - Instituto de Investigación contra la Leucemia Josep Carreras, Campus HGTiP

Grupo de Epigenética y enfermedades inmunitarias

Bioinformatics developments based on network and systems biology to identify new candidate genes for rare genetic diseases
Fundación Jiménez Díaz

Área de Genética y Genómica

Targeting tumors with nf1 loss
Institution: Information not provided - US

A powerful web-based discovery platform for rare disease genetics
Institution: Information not provided - US

Functional and translational studies of runx1 and cbfb in hematopoiesis
Institution: Information not provided - US

Neuro-ophthalmic mechanisms of disease
Institution: Information not provided - US

Tnf-receptors and programmed cell death in regulation of autoimmunity
Institution: Information not provided - US

Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis
Institution: Information not provided - US

Mechanisms of nf1 pathophysiology underlying hyperactivity
Institution: Information not provided - US

Social competence in youth with neurofibromatosis type 1
Institution: Information not provided - US

Genetic basis of immunodeficiency diseases
Karolinska Institutet - Huddinge

Department of laboratory medicine

Novel immunodeficiency unravels immune homeostasis mechanism
AKH BT 25.3

Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases

Empowering Families through Technology: a mobile-health project to reduce the TAND identification and treatment gap (TANDem)
Universitair Ziekenhuis Brussel

Pediatric neurology / Neurologie Kinderen

Pathobiology and robosomal insufficiency in Shwachman-Diamond syndrome
Hospital for Sick Children, Research Institute

Development of cell and gene therapy for blood disorders, in particularly Gaucher and Blackfan-Diamond diseases
Seoul National University Hospital

Molecular Diagnostics Laboratory

Pig models for Ataxia telangiectasia and Batten disease
Faculty of Medicine and University Hospital Motol

Department of Pediatrics

Modeling Rubinstein Taybi Syndrome Functionalization of a Rare Monogenic Disease and Therapeutic Potential of Stress Response Pathways in Neuropathies.
Université Paris Diderot

Unité Epigénétique et Destin Cellulaire CNRS UMR7216

RIBODBA: Blackfan-Diamond anemia: molecular mechanisms of a ribosomal disease
Université Paul Sabatier

Laboratoire de Biologie Moléculaire Eucaryote - UMR 5099

Phase IV Study: Status of the growth hormone/ insulin-like growth factor-1 axis in relation to growth failure, body weight and neuroprotection in children with Ataxia Telangiectasia
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt

Schwerpunkt Allergologie, Pneumologie und Mukoviszidose

Preclinical Gene Therapy of Fanconi Anemia with Transposon-Based Approaches
Paul-Ehrlich-Institut

Abteilung Medizinische Biotechnologie

BioTyrosin - Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1: An international, multicenter, epidemiological protocol
Centogene AG

Identification of molecular causes of human growth retardation in patients with features of Silver-Russell syndrome
Universitätsklinikum Aachen

Institut für Humangenetik

German Renal Cell Tumor Network: Molecular and clinical characterization of papillary renal cell carcinoma type II
Universitätsklinikum des Saarlandes

Klinik für Urologie und Kinderurologie

Evidence creation through nationwide surveillance of the progeria syndrome Werner syndrome and establishment ofa case registration system
Graduate School of Medicine, Chiba University

Pathogenesis and novel therapeutic approarches in RASoapthies
Tohoku University School of Medicine

Department of Medical Genetics

Drug Screening and development of rapid diagnostic technique for the DNA methylation abnormality due to the mutation in histone modification enzymes
Atomic Bomb Disease Institute, Nagasaki University

Department of Human Genetics

Study of clinical features and treatment of imprinting disorders and related disorders
National Center for Child Health and Development

Department of Molecular Endocrinology

Development of RAS-related ALPS-like disease (RALD) therapy
Tokyo Medical and Dental University

Pediatrics and Developmental Biology

Screening of novel therapeutics for intellectual disability and autism in tuberous sclerosis complex
Tokyo Metropolitan Institute of Medical Science

Department of Brain Development and Neural Regeneration

Effetto del fondatore nelle muatazioni del gene ATM in famiglie italiane affette da Atassia Teleangiectasia
A.O. S. Andrea

Servizio di Genetica Medica

Studio della patogenesi dei fenomeni autoimmune nelle immunodeficienze primitive
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

U.O. di Immunoinfettivologia Pediatrica

Caratterizzazione clinica e molecolare di sindromi genetiche con cardiopatie congenite
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO

U.O.C. Laboratorio di Genetica Medica

La Drosophila come organismo modello per lo studio della Nijmegen Breakage Syndrome e delle malattie ad essa correlate
Sapienza Università di Roma

Dipartimento di Genetica e Biologia Molecolare

Trasferimento delle nuove tecnologie nella diagnosi corrente di malattie genetiche rare a meccanismi eziopatogenetici multipli
Istituto Auxologico Italiano

Laboratorio di Biologia Molecolare

Production of vectors for gene therapy (Wiskott-Aldrich Syndrome and Metachromatic Leukodystrophy)
Istituto San Raffaele Telethon per la Terapia Genica - TIGET

Istituto San Raffaele Telethon per la Terapia Genica

Sindrome di Wiskott-Aldrich: caratterizzazione dei difetti immunologici e studi preclinici di terapia genica
Istituto San Raffaele Telethon per la Terapia Genica - TIGET

Unità di Ricerca Clinica

L'inibizione di DGK-alfa accende un nuovo interruttore che determina il destino cellulare dei linfociti T attivati: implicazioni per la terapia di XLP1
Università degli Studi del Piemonte Orientale

Centro Interdisciplinare di Ricerca sulle Malattie Autoimmuni

L'inibizione di DGK-alfa accende un nuovo interruttore che determina il destino cellulare dei linfociti T attivati: implicazioni per la terapia di XLP1
Università degli Studi del Piemonte Orientale

Dipartimento di Scienze Mediche

Screening per carcinoma midollare della tiroide e studio del genotipo nelle forme familiari
Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza

U.O.S. di Endocrinologia

Effectiveness and safety of mTOR-inhibitor in patients with tuberous sclerosis complex
Oslo University Hospital, Ullevaal

NevSom - Nasjonalt kompetansesenter for nevroutviklingsforstyrrelser og hypersomier

Causes of Rubinstein-Taybi Syndrome
Amsterdam UMC, locatie AMC

Kinderpolikliniek Klinische Genetica

Keloid formation in Rubinstein-Taybi Syndrome
Amsterdam UMC, locatie AMC

Kinderpolikliniek Klinische Genetica

Causes of Rubinstein-Taybi Syndrome
Amsterdam UMC, locatie AMC

Polikliniek Algemene Kindergeneeskunde

The Fundamentals of Phagocytosis: Integrating Theoretical Models and Experiments
University of Exeter, Physics building

Department of Physics and Astronomy